Investing Better Than George Soros

Friday, 13 Jul 2007 | 11:39 AM ET

Don’t invest like George Soros, invest better than George Soros, Cramer said tonight.

Even a billionaire like Soros, the man who broke the British pound, will have some poor picks in his portfolio. So Cramer wants only the best. That’s why he’s leaving stocks like Bon Ton and Qualcomm behind for a gem like Gen-Probe.

Investing Like Soros
Mad Money host Jim Cramer tells you how to invest like George Soros.

Gen-Probe is a diagnostics company in an industry that Cramer said is on a tear. It makes tests for sexually transmitted diseases and pneumonia. GPRO has two new products to boot: one for West Nile and the other for HIV, Hepatitis B and Hep C. There are tests on deck for prostate cancer and HPV as well. Cramer likes the company so much – it’s “instant growth” – he thinks Abbot Labs should buy it to boost its own ailing diagnostics division.

Gen-Probe enjoys a 40% market share since it’s one of only two diagnostics firms approved to screen donated blood, thanks to big government regulation. The company also has alliances with GE, parent company of CNBC, 3M and Millipore to extend GPRO tests into new areas.

Gen-Probe is a pastiche of different diagnostic tests for different diseases all in one stock. Good for Soros that he owns some, Cramer said.

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change


Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.